1. Including Pharmaceuticals in Bundled Payments

   • Gerard F. Anderson
   • Andrew York
   • Joshua L. Choe

   Commentary 08 July 2022 Pages: 625 - 628

2. Using Economics to Impact Local Obesity Policy: Introducing the UK Centre for Economics of Obesity (CEO)

   • Emma Frew
   • Nafsika Afentou
   • Irina Pokhilenko

   Current Opinion Open access 20 June 2022 Pages: 629 - 635

3. Centralised Pharmaceutical Procurement: Learnings from Six European Countries

   • Sabine Vogler
   • Eveli Bauer
   • Katharina Habimana

   Practical Application 06 May 2022 Pages: 637 - 650

4. Supply-Side Cost-Effectiveness Thresholds: Questions for Evidence-Based Policy

   • Chris Sampson
   • Bernarda Zamora
   • Adrian Towse

   Review Article Open access 07 June 2022 Pages: 651 - 667

   

5. UroLift for Treating Lower Urinary Tract Symptoms of Benign Prostatic Hyperplasia: A NICE Medical Technology Guidance Update

   • Laura Knight
   • Megan Dale
   • Rhys Morris

   Review Article Open access 18 July 2022 Pages: 669 - 680

6. An Economic Evaluation of Government-Funded COVID-19 Testing in Australia

   • Jonathan Karnon
   • Hossein Haji Ali Afzali
   • Billie Bonevski

   Original Research Article Open access 02 August 2022 Pages: 681 - 691

   

7. Information Asymmetry in Hospitals: Evidence of the Lack of Cost Awareness in Clinicians

   • Jeremy Fabes
   • Tuba Saygın Avşar
   • The Health Economics Survey Group

   Original Research Article 24 May 2022 Pages: 693 - 706

8. Does the Choice of Health Metric, DALY or QALY, Influence Conclusions of Health Economic Evaluation? A Case Study of Rotavirus Vaccine in Burundi

   • Fulgence Niyibitegeka
   • Montarat Thavorncharoensap
   • Sitaporn Youngkong

   Original Research Article 26 April 2022 Pages: 707 - 716

9. Economic Evaluation of a Tumour-Agnostic Therapy: Dutch Economic Value of Larotrectinib in TRK Fusion-Positive Cancers

   • Renée E. Michels
   • Carlos H. Arteaga
   • Marieke Krol

   Original Research Article Open access 18 July 2022 Pages: 717 - 729

   

10. ENTIMOS: A Discrete Event Simulation Model for Maximising Efficiency of Infusion Suites in Centres Treating Multiple Sclerosis Patients

    • Kristyna Lacinova
    • Praveen Thokala
    • Nicholas Adlard

    Original Research Article Open access 19 May 2022 Pages: 731 - 742

    

11. Economic Evaluation of Triple Therapy with Budesonide/Glycopyrrolate/Formoterol Fumarate for the Treatment of Moderate to Very Severe Chronic Obstructive Pulmonary Disease in China Using a Semi-Markov Model

    • Jia Liu
    • Xiaoning He
    • Jing Wu

    Original Research Article 28 April 2022 Pages: 743 - 755

    

12. Value and Price of Multi-indication Cancer Drugs in the USA, Germany, France, England, Canada, Australia, and Scotland

    • Daniel Tobias Michaeli
    • Mackenzie Mills
    • Panos Kanavos

    Original Research Article Open access 11 July 2022 Pages: 757 - 768

    

13. Cost-Effectiveness and Budget Impact Analysis of Implementing a 'Soft Opt-Out' System for Kidney Donation in Australia

    • Sameera Senanayake
    • Helen Healy
    • Sanjeewa Kularatna

    Original Research Article Open access 18 July 2022 Pages: 769 - 779

    

14. Correction to: Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations

    • Don Husereau
    • Michael Drummond
    • Sophie Staniszewska

    Correction Open access 15 July 2022 Pages: 781 - 782